Search Results
Jan 09, 2026, 02:00 ET Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology
collaboration with RedRidge Bio is underway to identify and develop biparatopic antibodies for multiple targets in precision oncology, dermatology, and rare diseases. These new additions to the discovery and clinical development portfolio complement Pierre Fabre Laboratories' existing precision oncology
More news about: Pierre Fabre Laboratories
Jan 09, 2026, 02:00 ET Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology
collaboration with RedRidge Bio is underway to identify and develop biparatopic antibodies for multiple targets in precision oncology, dermatology, and rare diseases. These new additions to the discovery and clinical development portfolio complement Pierre Fabre Laboratories' existing precision oncology
More news about: Pierre Fabre Laboratories
Jan 08, 2026, 16:30 ET PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
biopharmaceutical company dedicated to the discovery, development, and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class
More news about: PTC Therapeutics, Inc.
Jan 08, 2026, 16:05 ET BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
available through the Company's website for a limited time following the conference. About BioMarinBioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael,
More news about: BioMarin Pharmaceutical Inc.
Jan 08, 2026, 16:05 ET Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer
development deals in the past five years. Tom played a pivotal role in the approval and launch of Modeyso™ (dordaviprone), the first treatment for an ultra-rare, aggressive brain tumor affecting primarily children and young adults. His commitment to patients who previously had no options is truly inspiring.
More news about: Jazz Pharmaceuticals plc
Jan 08, 2026, 15:48 ET Osprey Real Estate Capital and Bruin Capital Partners Close 13-Acre Retail Site at I-11 and Kyle Canyon Road in the Sunstone Master Plan in 56 Days
nationally recognized retailers."Northwest Las Vegas is one of the most supply-constrained retail markets in the region, and this site gives us a rare opportunity to deliver a truly best-in-class shopping center to a rapidly growing community," said Sean Dalesandro, CEO of Osprey Real Estate Capital.
More news about: Osprey Real Estate Capital
Jan 08, 2026, 15:20 ET New Grey Matter Episode: James Quincey, Chairman and CEO of The Coca-Cola Company Talks Stewarding Change with Declan Kelly of Consello
decision-making, why simplifying the organization strengthened its focus, and how leaders act decisively without waiting for perfect information. It's a rare look at how large systems perform under changing conditions—and what it means to protect an iconic brand while still innovating.About ConselloConsello
More news about: Consello
Jan 08, 2026, 14:30 ET Adam Pollak Joins Portage Point Partners as Head of Advisory
Matthew Ray, Founder and Chief Executive Officer of Portage Point. "Adam brings the rare combination of operational and technology transformation leadership needed to evolve our Advisory platform and continue delivering differentiated, best-in-class
More news about: Portage Point Partners
Jan 08, 2026, 14:00 ET ELLE FANNING, MARK HAMILL, MYRON KERSTEIN, ZOEY DEUTCH, AND WAGNER MOURA TO BE HONORED AT THE ASTRA FILM AWARDS ON JANUARY 9, 2026
performances, bold creative choices, and an uncompromising commitment to the art of storytelling across stage, screen, and beyond. Hamill is one of the rare performers whose career seamlessly spans film, television, video games, and theater, leaving an indelible mark on every medium he has touched. He became
More news about: The Astra Awards
Jan 08, 2026, 10:30 ET Genomic Biomarkers Market worth $50.31 billion by 2030 | MarketsandMarkets™
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48860286 The genomic biomarkers market is experiencing growth due to several key factors, including the growing use of genomic testing in oncology, rare diseases, and inherited disorders, and rapid advancements in NGS, PCR, and multi-omics technologies.Emerging advances, such as AI-assisted NGS
More news about: MarketsandMarkets
Jan 08, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ: RARE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980,
More news about: Pomerantz LLP
Jan 08, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ramaco Resources, Inc. - METC
about joining the class action]On October 23, 2025, Wolfpack Research published a report alleging, among other things, that Ramaco's rare earth's project, Brook Mine, was a "hoax" and that the Company had "manipulated key data" to make Brook Mine "appear profitable to investors."On
More news about: Pomerantz LLP
Jan 08, 2026, 10:00 ET PAX SERVICES GROUP PROMOTES TIFFANY DUNCAN TO CHIEF REVENUE OFFICER
process, and performance—making her promotion a natural reflection of PAX's commitment to results-driven leadership and collaborative growth. She brings a rare combination of strategic insight, operational rigor, and hands-on leadership, and her relentless focus on execution and collaboration has elevated our
More news about: PAX Services Group
Jan 08, 2026, 10:00 ET CORCORAN ANNOUNCES NEW FRANCHISEE IN VIRGINIA WITH LAUNCH OF CORCORAN WILEY
"Central Virginia offers a rare blend of natural beauty, cultural depth, and enduring real estate value," said Liebman. "Justin, Peter, and their affiliated agents bring unparalleled
More news about: The Corcoran Group
Jan 08, 2026, 09:00 ET CBCC Global Research Rebrands to REV Clinical to Reflect Next Stages of Growth
with deep experience in designing and managing clinical trials across its core therapeutic areas, including oncology, neurology, ophthalmology, and rare diseases, today announced the launch of its comprehensive rebrand and name change to REV Clinical, reflecting the organization's focus on designing
More news about: REV Clinical
Jan 08, 2026, 09:00 ET Screenvision Announces Leadership Transition
strong foundation J.P. and this team have established over the past decade." "My last 10 years of leading this company have been a rare privilege," said Mr. Partilla. "Together, we've driven record revenue years, successfully navigated the challenges of the pandemic and positioned
More news about: Screenvision Media
Jan 08, 2026, 09:00 ET StrongestLayer Research Finds Trusted Platforms Like DocuSign and Google Calendar Are Now the Primary Email Attack Surface
relying on malware or obvious phishing techniques, today's attackers exploit trust, authentication gaps, and operational dependency. The report provides rare visibility into the techniques that define modern email threats by examining only attacks that incumbent security controls missed."Email security
More news about: StrongestLayer
Jan 08, 2026, 08:41 ET Voices of Distinction: Ten Professionals Creating Enduring Impact
Year.Dr. Sanjeev Kumar: Dr. Sanjeev Kumar is a distinguished scholar, entrepreneur, and Supreme Court advocate whose career reflects a rare integration of literature, law, and leadership. He holds a Doctor of Literature (D.Lit.) along with advanced qualifications from MIT, Boston, the Institute
More news about: Kiteskraft Productions LLP
Jan 08, 2026, 08:31 ET Arkstone Taps Ian Campbell as CEO to Lead Next Phase of Growth and Innovation
precision-guided clinical decision support, after the company's recent early-stage funding from ARCHIMED's MED Rise fund. "Ian is a proven leader with a rare ability to scale technically complex platforms and successfully guide organizations through transformational growth and acquisition," said Ari Frenkel,
More news about: Arkstone
Jan 08, 2026, 08:30 ET Veeva and BioMarin Form Long-Term Strategic Partnership
they advance important new medicines and reach even more patients around the world."About BioMarinBioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael,
More news about: Veeva Systems
Jan 08, 2026, 08:30 ET Veeva and BioMarin Form Long-Term Strategic Partnership
they advance important new medicines and reach even more patients around the world."About BioMarinBioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael,
More news about: Veeva Systems
Jan 08, 2026, 08:15 ET AMLM Announces Strategic Acquisition of Potentially Major Silver and Copper Projects in Chile
Lithium Materials, Inc. American Lithium Materials, Inc. (OTCID: AMLM)) is an exploration-stage mining company focused on gold, lithium, rare earths, cobalt, nickel, and other critical metals powering the global energy transition. Now entering a transformation phase, AMLM is being repositioned
More news about: American Lithium Minerals, Inc
Jan 08, 2026, 08:00 ET Safi Biotherapeutics and ARMI | BioFabUSA Complete Successful Technical Transfer of Initial Clinical Scale 10L mRBC Production System
launched the company in 2020 as part of the U.S. Department of Defense On-Demand Blood program. Safi's mRBC product has been granted U.S. FDA Rare Pediatric Disease Designation and Orphan Drug Designation for use in chronic transfusion of patients with SCD.For more information on Safi, visit:
More news about: Safi Biotherapeutics
Jan 08, 2026, 08:00 ET Hartford edges out Buffalo to become Zillow's hottest market for 2026
list of hottest markets for 2026, followed by Providence and San Jose to round out the top five. In these markets, Zillow expects price cuts to be rare, listings to move fast and strong price growth.Inventory is still 63% below pre-pandemic levels in Hartford, the largest deficit among the 50
More news about: Zillow
Jan 08, 2026, 07:00 ET Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of VK2735 in Obesity
of internally developed dual amylin and calcitonin receptor agonists (or DACRAs) for the treatment of obesity and other metabolic disorders. In the rare disease space, Viking is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential
More news about: Viking Therapeutics, Inc.